One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety profile in a once daily pill for moderate-to-severe plaque psoriasis ...
{{ .fieldName }} // Get field from current item +{{ ["field with spaces"] }} // Field names with spaces/special chars +Stop searching through documentation! This ...
LEO Pharma A/S, a global leader in medical dermatology, today announced new long-term results from EFFISAYIL ® ON, an ongoing five-year open-label extension study of the pivotal ...
Could horses race in GEHA Field at Arrowhead Stadium after the Chiefs move to Kansas? That's just one imaginative idea Truman ...
EO14168 has been overwhelmingly responsible for driving changes to federal forms and survey data,” says Melanie Klein, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results